COSSIGA, VALENTINA
 Distribuzione geografica
Continente #
AS - Asia 1.898
NA - Nord America 1.145
EU - Europa 1.080
SA - Sud America 271
AF - Africa 49
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.450
Nazione #
US - Stati Uniti d'America 1.088
SG - Singapore 801
RU - Federazione Russa 572
CN - Cina 424
VN - Vietnam 352
BR - Brasile 226
IT - Italia 152
DE - Germania 101
HK - Hong Kong 101
FR - Francia 62
GB - Regno Unito 52
JP - Giappone 48
NL - Olanda 48
IN - India 39
KR - Corea 39
CA - Canada 29
CI - Costa d'Avorio 19
AR - Argentina 17
MX - Messico 16
FI - Finlandia 15
PL - Polonia 14
ZA - Sudafrica 14
BD - Bangladesh 13
UA - Ucraina 12
PH - Filippine 11
ES - Italia 10
IQ - Iraq 10
TH - Thailandia 9
AT - Austria 8
ID - Indonesia 8
EC - Ecuador 7
LT - Lituania 7
SE - Svezia 7
TR - Turchia 7
IE - Irlanda 6
VE - Venezuela 6
CL - Cile 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
HN - Honduras 4
JO - Giordania 4
PE - Perù 4
AM - Armenia 3
AZ - Azerbaigian 3
BE - Belgio 3
CO - Colombia 3
EG - Egitto 3
KE - Kenya 3
PY - Paraguay 3
SA - Arabia Saudita 3
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
CY - Cipro 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
LV - Lettonia 2
MA - Marocco 2
NZ - Nuova Zelanda 2
TW - Taiwan 2
UZ - Uzbekistan 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LC - Santa Lucia 1
ML - Mali 1
MY - Malesia 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PF - Polinesia Francese 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
TN - Tunisia 1
ZM - Zambia 1
Totale 4.450
Città #
Singapore 437
San Jose 283
Hefei 192
Moscow 137
Ashburn 113
Ho Chi Minh City 102
Hong Kong 97
Beijing 94
Hanoi 69
Santa Clara 61
Lauterbourg 42
Tokyo 42
Chandler 41
Amsterdam 38
Los Angeles 37
Seoul 35
Naples 31
The Dalles 31
New York 28
Frankfurt am Main 22
Munich 22
Düsseldorf 20
São Paulo 20
Buffalo 19
Council Bluffs 19
Kochi 17
Da Nang 16
Chicago 15
Redondo Beach 15
London 13
Millbury 13
Orem 13
Dallas 12
Haiphong 12
Warsaw 12
Helsinki 11
Mexico City 10
Poplar 10
Toronto 10
Lawrence 9
Milan 9
Nuremberg 9
Brooklyn 8
Manchester 8
Can Tho 7
Des Moines 7
Johannesburg 7
Napoli 7
Rio de Janeiro 7
Stockholm 7
Turin 7
Bangkok 6
Biên Hòa 6
Denver 6
Falkenstein 6
Hải Dương 6
Jacksonville 6
Montreal 6
Porto Alegre 6
San Francisco 6
Vienna 6
Ankara 5
Atlanta 5
Boston 5
Chennai 5
Dublin 5
Ninh Bình 5
Phoenix 5
Portsmouth 5
Seattle 5
Afragola 4
Baghdad 4
Baronissi 4
Brasília 4
Dong Ket 4
Mumbai 4
Rochdale 4
Rome 4
Santa Maria La Carità 4
Thái Nguyên 4
Tân Tiến 4
Amman 3
Bologna 3
Brussels 3
Cairo 3
Caivano 3
Cape Town 3
Capodrise 3
Contagem 3
Curitiba 3
Guayaquil 3
Jeddah 3
Joinville 3
Jundiaí 3
Legnaro 3
Lima 3
Niterói 3
Nova Iguaçu 3
Ourinhos 3
Querétaro 3
Totale 2.509
Nome #
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 176
Anti-HDV reflex testing in HBsAg-positive subjects: An efficacious strategy to identify HDV infection 160
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 158
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 149
Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study 141
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 139
Pattern of macrovascular invasion in hepatocellular carcinoma 138
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 135
Use of Telemedicine for chronic liver disease at a single care center during the COVID-19 pandemic: Prospective observational study 135
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 134
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 134
Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents 130
Berberis aristata, elaeis guineensis and coffea canephora extracts modulate the insulin receptor expression and improve hepatic steatosis in NAFLD patients: A pilot clinical trial 130
Metabolic-associated fatty liver disease (MAFLD) in coeliac disease 130
Effectiveness of Hepatitis B Vaccination Campaign in Italy: Towards the Control of HBV Infection for the First Time in a European Country 125
Risk stratification of HCC occurrence after HCV eradication: a complicate plot of risk factors related and unrelated to the previous viral disease 124
The combination of berberine, tocotrienols and coffee extracts improves metabolic profile and liver steatosis by the modulation of gut microbiota and hepatic mir‐122 and mir‐34a expression in mice 124
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 117
Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients 116
Relevance of Bile Acids in Cholangiocarcinoma Pathogenesis: Critical Revision and Future Directions 115
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study 115
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma 113
Acute Delta Hepatitis in Italy spanning three decades (1991-2019): Evidence for the effectiveness of the hepatitis B vaccination campaign 113
Visceral Obesity and Cytokeratin-18 Antigens as Early Biomarkers of Liver Damage 112
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 110
The interpretation of liver function tests in pregnancy 110
Safety and Immunogenicity of Anti-SARS-CoV-2 Booster Dose in Patients with Chronic Liver Disease 105
Non-invasive assessment of portal hypertension in patients with primary biliary cholangitis is affected by severity of cholestasis 103
COVID-19 and Fatty Liver Disorders 102
The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight 99
Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma 95
Ribociclib in newly diagnosed hepatitis B infection: A case report 93
Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review 90
Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study 89
The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis 87
Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature 73
Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice 62
Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open! 59
Vascular liver diseases: A sex-oriented analysis of the literature 59
Refined classification and phenotype-driven analysis of PIEZO1 variants in hereditary red cell and iron disorders 6
Uncovering hidden HCV infections in adults over 55: reflex testing and insights for opportunistic screening in a tertiary care setting 2
Totale 4.507
Categoria #
all - tutte 13.197
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.197


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 1 5
2021/202255 0 0 0 0 0 0 1 1 0 8 22 23
2022/2023130 9 2 4 6 25 11 6 2 10 40 12 3
2023/2024216 5 59 39 18 5 9 3 23 3 15 22 15
2024/20251.318 55 47 2 23 40 70 126 103 98 124 532 98
2025/20262.729 261 342 325 305 451 115 302 167 256 150 55 0
Totale 4.507